Director, Medical Communications
Immatics
About this role
A Director, Medical Communications at Immatics leads global medical publications, congress strategy, and launch-critical scientific dissemination for priority programs, with a focus on anzu-cel market preparation and launch readiness. The role involves translating emerging data into clear narratives for stakeholders, managing scientific platforms, and driving data dissemination.
Skills
Qualifications
About Immatics
immatics.comImmatics combines the discovery of cancer targets with T cell receptor development to create Adoptive Cell Therapies and TCR Bispecifics.
Recent company news
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate
2 hours ago
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)
4 days ago
Immatics (NASDAQ:IMTX) Sees Strong Trading Volume - Here's What Happened
2 days ago
Is Immatics’ 2025 Loss and PRAME Pipeline Push Altering The Investment Case For Immatics (IMTX)?
3 days ago
Immatics: Q4 Earnings Snapshot
1 week ago
About Immatics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Immatics.
Salary
$220k – $270k
per year
More jobs at Immatics
Similar Jobs
Executive Director, Scientific Communications
Travere Therapeutics
Director, Global Medical Immunology & Cardiovascular, Medical Communications (Pulmonology)
0468 BMS Polska Sp. z o.o.
Associate Director, Medical Communications & Publications - Rare Disease
Ipsen
Associate Director/Director, Scientific Communications
Cognito Therapeutics
Senior Director, Medical Communications
Revolution Medicines
Associate Director, Scientific Communications Lead, Solid Tumors, Global Medical Affairs Oncology
Takeda Pharmaceutical Company